Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Uniform Quality Standards for a Quarter of a Century

Published: Wednesday, February 27, 2013
Last Updated: Tuesday, February 26, 2013
Bookmark and Share
SCHOTT Tubing has been publishing technical delivery specifications for pharmaceutical tubing for 25 years.

The international technology group SCHOTT has been documenting and publishing technical terms of supply for its glass tubing for use in pharmaceutical applications for 25 years now.

In fact, SCHOTT became the first company in the industry to provide its customers with exact specifications of the most important product parameters in 1988.

Since then, the ongoing improvements that have been made to its special glass tubing used to produce vials, syringes, cartridges and ampoules have been anchored in its terms of supply and thus made visible for its customers.

SCHOTT constantly strives to make improvements that flow into its quality standards to accommodate changing market demands, the needs of its customers and its own goal of providing its customers with maximum benefits.

A revised version of its technical delivery specifications is published about every three years.

“At SCHOTT Tubing, we have been setting the standards on manufacturing glass tubing for 25 years with our technical terms of supply. This means we are committed to constantly improving our production process and offer our customers the highest possible transparency and quality assurance,” says Jürgen Achatz, Global Sales Director for Pharmaceutical Tubing at SCHOTT.

In addition to a description of the products in which all of the characteristics of relevance to its customers are defined in great detail, the technical delivery specifications also include precisely determined tolerance ranges.

SCHOTT’s delivery specifications differ from its competitors’ technical terms of delivery not only in terms of their vast depth of detail and clarity.

The company also subjects its specification to further review by the Federal Association of the German Glass Industry.

The specialized group “Primary Packaging” discusses and evaluates the company’s standards, whereby the results flow directly into the final version of the delivery specifications.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
Non-Toxic Approach to Treating Variety of Cancers
A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine recently discovered a novel, non-toxic approach to treating a wide variety of cancers.
Making Injectable Medicine Safer
Researchers remove excess additives from drugs, which could reduce the odds of serious allergic reactions and other side effects.
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!